ABHIRAM KUMAR

Employment

• Birla Institute of Technology and Science - Hyderabad Campus Research Associate
  2024 - Present
• Esperer Onco Nutrition Pvt. Ltd. cell culture, Cancer Biology, Nutraceutical formulation development, etc
  2021 - 2023
• CSIR-Central Drug Research Institute, Lucknow, India Project Assistant (Bio-analytical method development, PF/PD)
  2018 - 2021
• Alembic Pharmaceuticals (India) Method validation and Verification, Technology Transfer, Instruments qualifications
  2017 - 2018
• Ipca Laboratories (India) Jr. Scientific Officer
  2016 - 2017

Education

• Birla Institute of Technology and Science - Hyderabad Campus PhD
  2021 - 2025
• Uttarakhand Technical University Master in Pharmaceutical Sciences
  2013 - 2015
• Annamalai University B. Pharm
  2009 - 2013

Projects & Funding

Projects & funding information is unavailable.

Publications (19)

• Recent Advances in Nanotherapeutics and Theranostics for Squamous Cell Carcinoma: A Comprehensive Review
  Current Drug Delivery 2026 DOI: 10.2174/0115672018342513241230061704
  +Save
• Biodegradable Lipids and Surfactants
  2026 DOI: 10.4018/979-8-3373-3765-4.ch001
  +Save
• An in situ-forming injectable silk hydrogel with a cocktail of chemotherapeutic drugs simultaneously targeting cancer cells and cancer stem cells
  Journal of Materials Chemistry B 2026 DOI: 10.1039/D5TB02316E
  +Save
• Microbiota-derived metabolite landscapes modulate Fusobacterium fitness and colorectal cancer cell behaviour
  Gut Pathogens 2026 DOI: 10.1186/s13099-026-00859-9
  +Save
• Artificial Intelligence in Detecting and Diagnosing Microbiome-Driven Cancer
  Enhancing Autonomous and Adaptive Systems With AI and IoT 2025
  +Save
• Artificial Intelligence in Detecting and Diagnosing Microbiome-Driven Cancer
  2025 DOI: 10.4018/979-8-3373-3146-1.ch012
  +Save
• A Concurrent Review on Plant-Derived Biopesticides and Synthetic Pesticides: Their Importance in Plant Protection and Impacts on Human Health
  Nature Environment and Pollution Technology 2025 DOI: 10.46488/NEPT.2025.v24i03.B4286
  +Save
• Development of a quality by design based hybrid RP-HPLC method for Glimepiride: Bioanalytical and industrial applications
  Journal of Applied Pharmaceutical Science 2025 DOI: 10.7324/JAPS.2025.214654
  +Save
• Fabrication of Polymeric Matrix Type Transdermal Patch Containing Glimepiride for Therapeutic Management of Type-2 Diabetes
  Indian Journal of Pharmaceutical Education and Research 2025 DOI: 10.5530/ijper.20250924
  +Save
• Nanotherapeutics
  2024 DOI: 10.4018/979-8-3693-7728-4.ch007
  +Save